ScopeUniversitätsklinikum Frankfurt Zentrum der Inneren Medizin, Medizinische Klinik 2 Hämatologisch-Onkologisches Speziallabor
42 capabilities
Accredited since June 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Theodor-Stern-Kai 7
Frankfurt am Main 60590 , Germany
Frankfurt am Main 60590 , Germany
Accreditation
Active
DAkkS
D-ML-13102-06-00
Specialises in haematology-oncology laboratory diagnostics, including flow cytometry analysis of bone marrow and peripheral blood samples for clinical chemistry and molecular genetic investigations.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13102-06-00
Status
ActiveSince
25 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (42)
| Standard Reference | Description | Category |
|---|---|---|
| Zellzahlbestimmung | Zellzahlbestimmung | Clinical Chemistry |
| (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53) | (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53) | Elemental Analysis |
| (BRCA2) | (BRCA2) | Elemental Analysis |
| CEBPA | exon11, FLT3-ITD, CEBPA | Elemental Analysis |
| IDH1 exon 4, IDH2 exon | IDH1 exon 4, IDH2 exon | Elemental Analysis |
| Mutation bei der AML (IDH1) | Mutation bei der AML (IDH1) | Elemental Analysis |
| RUNX1, SETBP1, SF3B1, TET2, TP53, U2AF1) | RUNX1, SETBP1, SF3B1, TET2, TP53, U2AF1) | Elemental Analysis |
| SETBP1, SF3B1, SRSF2, TET2, U2AF1) | SETBP1, SF3B1, SRSF2, TET2, U2AF1) | Elemental Analysis |
| Zell-Differenzierung von | Zell-Differenzierung von | Food Safety Testing |
| Akuten Leukämien | Akuten Leukämien | Hematology |
| Charakterisierung von akuten | Charakterisierung von akuten | Hematology |
| Manuel les Differential-Blutbild | manuelles Differentialblutbild | Hematology |
| Ergußpräparaten (Zytospin) | Ergußpräparaten (Zytospin) | Histopathology / Cytology |
| Knochenmark | Knochenmark | Histopathology / Cytology |
| Zell-Differentierung von | Zell-Differentierung von | Histopathology / Cytology |
| (ABL1) | Leukämie (ABL1) | Molecular Diagnostics / PCR |
| (BRCA1 P002) | (BRCA1 P002) | Molecular Diagnostics / PCR |
| (BRCA1) | (BRCA1) | Molecular Diagnostics / PCR |
| (BRCA2/CHEK2 P045-B3) | (BRCA2/CHEK2 P045-B3) | Molecular Diagnostics / PCR |
| (FLT3-ITD) | Mutation bei der AML (FLT3-ITD) | Molecular Diagnostics / PCR |
| (FLT3-TKD) | Mutation bei der AML (FLT3-TKD) | Molecular Diagnostics / PCR |
| (NPM1) | Mutation bei der AML (NPM1) | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| Leukämie (GUS) | Leukämie (GUS) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-A) | Mutation bei der AML (NPM1-A) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-B) | Mutation bei der AML (NPM1-B) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-D) | Mutation bei der AML (NPM1-D) | Molecular Diagnostics / PCR |
| chromosomale Aberrationen | chromosomale Aberrationen | Molecular Diagnostics / PCR |
| AF9, MLL-ELL, MLL-PTD, MLF1, PML-RARA) | AF9, MLL-ELL, MLL-PTD, MLF1, PML-RARA) | Other |
| AML (Detektion der Fusionsgene | AML (Detektion der Fusionsgene | Other |
| B-Zellzahl (Immunstatus | B-Zellzahl (Immunstatus | Other |
| ETO(RUNX1-RUNX1T1)) | ETO(RUNX1-RUNX1T1)) | Other |
| Leukämien (Fusionsgen | Leukämien (Fusionsgen | Other |
| Leukämien (Minor - und | Leukämien (Minor - und | Other |
| MYH11) | MYH11) | Other |
| MYH11-A) | MYH11-A) | Other |
| MYH11-D) | MYH11-D) | Other |
| MYH11-E) | MYH11-E) | Other |
| Mutation bei MPN (JAK2 | Mutation bei MPN (JAK2 | Other |
| bcr1) | bcr1) | Other |
| bcr2) | bcr2) | Other |
| bcr3) | bcr3) | Other |